Trial Profile
Assessment of changes in metabolic activity in liver & skeletal muscle in patients suffering from acromegaly - a 31P/1H magnetic resonance spectroscopy pilot study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 23 Jul 2014
Price :
$35
*
At a glance
- Drugs Lanreotide (Primary)
- Indications Acromegaly
- Focus Therapeutic Use
- Acronyms THIGHT2
- 23 Jul 2014 New trial record